In-vitro Inflammatory Bowel Disease Diagnostic Market, Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: I2A7ED9F11A3EN
Market Monitor Global

Abstracts

Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.

This report contains market size and forecasts of In-vitro Inflammatory Bowel Disease Diagnostic in Global, including the following market information:

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In-vitro Inflammatory Bowel Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Assays/Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In-vitro Inflammatory Bowel Disease Diagnostic include DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL. and Biosystems S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-vitro Inflammatory Bowel Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Assays/Biomarker
• Analyzers

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Diagnostic Laboratories
• Hospitals
• Research Institutes

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In-vitro Inflammatory Bowel Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies In-vitro Inflammatory Bowel Disease Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• DiaSorin S.p.A
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott
• Quidel Corporation
• American Laboratory Products Company (ALPCO)
• Certest Biotec SL.
• Biosystems S.A.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IN-VITRO INFLAMMATORY BOWEL DISEASE DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size: 2021 VS 2028
2.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top In-vitro Inflammatory Bowel Disease Diagnostic Players in Global Market
3.2 Top Global In-vitro Inflammatory Bowel Disease Diagnostic Companies Ranked by Revenue
3.3 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 In-vitro Inflammatory Bowel Disease Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies In-vitro Inflammatory Bowel Disease Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-vitro Inflammatory Bowel Disease Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 In-vitro Inflammatory Bowel Disease Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 In-vitro Inflammatory Bowel Disease Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Assays/Biomarker
  4.1.3 Analyzers
4.2 By Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2021 & 2028
  5.1.2 Diagnostic Laboratories
  5.1.3 Hospitals
  5.1.4 Research Institutes
5.2 By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028
  6.3.2 US In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.3.3 Canada In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.3.4 Mexico In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028
  6.4.2 Germany In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.3 France In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.4 U.K. In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.5 Italy In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.6 Russia In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.4.8 Benelux In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028
  6.5.2 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.5.3 Japan In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.5.4 South Korea In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.5.6 India In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028
  6.6.2 Brazil In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.6.3 Argentina In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028
  6.7.2 Turkey In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.7.3 Israel In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028
  6.7.5 UAE In-vitro Inflammatory Bowel Disease Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 DiaSorin S.p.A
  7.1.1 DiaSorin S.p.A Corporate Summary
  7.1.2 DiaSorin S.p.A Business Overview
  7.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.1.4 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 DiaSorin S.p.A Key News
7.2 F. Hoffmann-La Roche Ltd
  7.2.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd Key News
7.3 Siemens Healthineers AG
  7.3.1 Siemens Healthineers AG Corporate Summary
  7.3.2 Siemens Healthineers AG Business Overview
  7.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.3.4 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Siemens Healthineers AG Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.4.4 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Abbott Key News
7.5 Quidel Corporation
  7.5.1 Quidel Corporation Corporate Summary
  7.5.2 Quidel Corporation Business Overview
  7.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.5.4 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Quidel Corporation Key News
7.6 American Laboratory Products Company (ALPCO)
  7.6.1 American Laboratory Products Company (ALPCO) Corporate Summary
  7.6.2 American Laboratory Products Company (ALPCO) Business Overview
  7.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.6.4 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 American Laboratory Products Company (ALPCO) Key News
7.7 Certest Biotec SL.
  7.7.1 Certest Biotec SL. Corporate Summary
  7.7.2 Certest Biotec SL. Business Overview
  7.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.7.4 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Certest Biotec SL. Key News
7.8 Biosystems S.A.
  7.8.1 Biosystems S.A. Corporate Summary
  7.8.2 Biosystems S.A. Business Overview
  7.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Major Product Offerings
  7.8.4 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Biosystems S.A. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. In-vitro Inflammatory Bowel Disease Diagnostic Market Opportunities & Trends in Global Market
Table 2. In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers in Global Market
Table 3. In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints in Global Market
Table 4. Key Players of In-vitro Inflammatory Bowel Disease Diagnostic in Global Market
Table 5. Top In-vitro Inflammatory Bowel Disease Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies In-vitro Inflammatory Bowel Disease Diagnostic Product Type
Table 9. List of Global Tier 1 In-vitro Inflammatory Bowel Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In-vitro Inflammatory Bowel Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - In-vitro Inflammatory Bowel Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. DiaSorin S.p.A Corporate Summary
Table 31. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 32. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 35. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Siemens Healthineers AG Corporate Summary
Table 37. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 38. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Corporate Summary
Table 40. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 41. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Quidel Corporation Corporate Summary
Table 43. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 44. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. American Laboratory Products Company (ALPCO) Corporate Summary
Table 46. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 47. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Certest Biotec SL. Corporate Summary
Table 49. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 50. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Biosystems S.A. Corporate Summary
Table 52. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Product Offerings
Table 53. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. In-vitro Inflammatory Bowel Disease Diagnostic Segment by Type in 2021
Figure 2. In-vitro Inflammatory Bowel Disease Diagnostic Segment by Application in 2021
Figure 3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2021
Figure 8. By Type - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 12. US In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 24. China In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE In-vitro Inflammatory Bowel Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)